Metformin lowers risk of late miscarriage, preterm birth in pregnant women with PCOS

March 20, 2018, The Endocrine Society

The oral diabetes medication metformin seems to reduce the chance of a late miscarriage and premature birth among women with polycystic ovary syndrome (PCOS) but does not affect their rate of developing gestational diabetes, a multicenter study finds. The results were presented Tuesday at ENDO 2018, the Endocrine Society's 100th annual meeting in Chicago, Ill.

Women with PCOS are at increased risk for infertility, and if they do become pregnant, they have a higher chance of , including miscarriage and , as well as a form of diabetes during pregnancy called . PCOS is the most common hormone disorder among females of childbearing age, affecting up to 10 percent of these women, according to the Hormone Health Network.

A total of 487 pregnant women with PCOS participated in the study at 14 research centers in Norway, Sweden and Iceland. They were randomly assigned to receive either daily metformin (2,000 milligrams) or an inactive placebo from their first trimester to delivery, but did not know which drug they received. The average age of participants was 29 years old. After excluding women who dropped out of the study, the researchers found that a combined incidence of late miscarriage (pregnancy loss in the second trimester) and (at less than 37 weeks of pregnancy) was almost halved in the women receiving metformin versus placebo.

Only 9 (5 percent) of the 211 women who completed the study in the metformin group experienced late miscarriage or preterm birth, compared with 23 (10 percent) of 223 women who received the placebo, the investigators reported.

"Metformin had this beneficial effect if the women adhered to the treatment," said Tone Loevvik, M.D., the study's lead investigator and a Ph.D. student at Norwegian University of Science and Technology in Trondheim, Norway. "Of the women who stayed in the study, 81 percent took more than 80 percent of their medication."

The study had a dropout rate of about 10 percent, which Loevvik said they consider "quite good" for this type of study.

The investigators found a similar frequency of gestational diabetes in the two study groups. Therefore, Loevvik said metformin appeared to have no effect in lowering the risk of this type of diabetes, which itself can raise the chance of pregnancy complications.

"This finding is disappointing but not surprising," Loevvik said. "It is in accordance with the results from two previous studies from our research group."

Metformin treatment, however, was associated with less weight gain during pregnancy. Loevvik said this was a positive finding because the study participants had an average , or BMI, of 29 kg/m2, which is overweight, and doctors recommend that women with overweight or obesity gain less weight during pregnancy than for healthy-weight women.

Doctors often prescribe for with PCOS to prevent type 2 diabetes. Metformin is approved for treatment of type 2 diabetes in the United States and Nordic countries and also for gestational diabetes in the Nordic countries.

Explore further: Diabetes drug use during pregnancy linked to child's weight

Related Stories

Diabetes drug use during pregnancy linked to child's weight

February 27, 2018
When women take the common diabetes medication metformin during pregnancy, it may put their children at increased risk of having obesity or overweight.

Diabetes, but not diabetes drug, linked to poor pregnancy outcomes

December 20, 2017
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes—such as major birth defects and pregnancy loss—than the general population, ...

Interventions lower diabetes risk in women who had gestational diabetes

February 23, 2015
Women with a history of gestational diabetes face a heightened risk of developing Type 2 diabetes for years after giving birth, but intensive lifestyle intervention or a medication regimen can have a protective effect in ...

PCOS sufferers appear to benefit from lifestyle modification combined with metformin

June 10, 2015
A systematic review publishing today in the journal Human Reproduction Update has found that women who suffer from polycystic ovary syndrome (PCOS) could manage some of the symptoms by combining a change in lifestyle with ...

Diabetes drug may prevent or delay development of polycystic ovary syndrome

June 29, 2011
A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) found that early, prolonged treatment with the diabetes drug metformin may prevent or delay the development ...

Diabetes drug may not help obese women have normal-weight babies

February 4, 2016
(HealthDay)—Giving the diabetes drug metformin to obese pregnant women may not help their newborns come into the world at a healthier weight, a new trial finds.

Recommended for you

Blood test may identify gestational diabetes risk in first trimester

August 16, 2018
A blood test conducted as early as the 10th week of pregnancy may help identify women at risk for gestational diabetes, a pregnancy-related condition that poses potentially serious health risks for mothers and infants, according ...

Artificial placenta created in the laboratory

August 14, 2018
In order to better understand important biological membranes, it is necessary to explore new methods. Researchers at Vienna University of Technology (Vienna) have succeeded in creating an artificial placental barrier on a ...

The inequalities of prenatal stress

August 14, 2018
Exposure to an acute stress in utero can have long-term consequences extending into childhood – but only among children in poor households, according to a new Stanford study that looked at the long-term impact of acute, ...

Better studies needed on effectiveness of fertility awareness-based methods for contraception

August 10, 2018
A new systematic review provides the most comprehensive assessment to date on the scientific evidence estimating the effectiveness of various fertility awareness-based methods (FABMs) for contraception. "Effectiveness of ...

Inducing labor at 39 weeks reduces likelihood of C-sections

August 8, 2018
Inducing labor in healthy first-time mothers in the 39th week of pregnancy results in lower rates of cesarean sections compared with waiting for labor to begin naturally at full term, according to a multicenter study funded ...

Three-dimensional model of human placenta developed

August 3, 2018
The placenta is the organ connecting mother and embryo. Its main functions are the exchange of nutrients, gases and metabolic products and the production of hormones and other substances essential for embryonic development. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.